Jul 8, 2014

CardioCell Launches Phase 2a Chronic Heart Failure Trial

 CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular indications, started its Phase 2a clinical trial for chronic heart failure (HF) patients with non-ischemic cardiomyopathy. READ FULL ARTICLE